An in silico Study of Carotenoids as Antioxidants through the KEAP1-NRF2 Pathway

Authors

DOI:

https://doi.org/10.59278/cbs.v5i14.116

Keywords:

β-carotene, KEAP1–NRF2 pathway, molecular docking, molecular dynamics, oxidative stress, ADMET

Abstract

Background: Oxidative stress contributes to the pathogenesis of numerous degenerative diseases, and activation of the Kelch-like ECH-associated protein 1 (KEAP1)–nuclear factor erythroid 2-related factor 2 (NRF2) pathway represents a potential antioxidant strategy. Aim: This study evaluated the potential of eight carotenoids to inhibit the KEAP1–NRF2 protein–protein interaction through binding to the KEAP1 Kelch domain. Methods: Molecular docking was performed using the human KEAP1 crystal structure (PDB ID: 4L7D) and the co-crystallized ligand 1VX as a reference. The tested carotenoids were α-carotene, β-carotene, β-cryptoxanthin, lycopene, lutein, zeaxanthin, astaxanthin, and fucoxanthin. The top-ranked compound was subsequently evaluated by a 50-ns molecular dynamics simulation and in silico pharmacokinetic and toxicity prediction. Results: Among the tested compounds, β-carotene showed the most favorable docking affinity (−9.95 kcal/mol; predicted Ki​: 51.10 nM), which was close to that of 1VX (−10.20 kcal/mol; predicted Ki: 33.47 nM). β-Carotene occupied the KEAP1 Kelch binding pocket through extensive hydrophobic interactions involving Tyr334, Tyr572, Phe577, Ala556, Arg415, and Arg336. Molecular dynamics simulation supported complex stability, with mean RMSD, RMSF, and radius of gyration values of 1.58 Å, 0.90 Å, and 17.91 Å, respectively. The KEAP1–β-carotene complex showed an average binding free energy of −22.57 kJ/mol, with persistent interactions at Tyr334 and Arg415. ADMET prediction indicated low oral bioavailability (0.17) and noncompliance with Lipinski’s Rule of Five, although β-carotene complied with Veber’s rule and was predicted to be non-hepatotoxic. Conclusion: In conclusion, β-carotene is a promising carotenoid scaffold for targeting the KEAP1 Kelch domain and potentially modulating NRF2 signaling.

References

1. Reddy VP. Oxidative Stress in Health and Disease. Biomedicines. 2023;11(11):2925. doi:10.3390/biomedicines11112925

2. Woo Y, Lee HJ, Jung YM, Jung YJ. mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance. J Oncol. 2019;2019:1-11. doi:10.1155/2019/5956867

3. Tumilaar SG, Hardianto A, Dohi H, Kurnia D. A Comprehensive Review of Free Radicals, Oxidative Stress, and Antioxidants: Overview, Clinical Applications, Global Perspectives, Future Directions, and Mechanisms of Antioxidant Activity of Flavonoid Compounds. Ahmed M, ed. J Chem. 2024;2024:1-21. doi:10.1155/2024/5594386

4. Muscolo A, Mariateresa O, Giulio T, Mariateresa R. Oxidative Stress: The Role of Antioxidant Phytochemicals in the Prevention and Treatment of Diseases. Int J Mol Sci. 2024;25(6):3264. doi:10.3390/ijms25063264

5. Li R, Jia Z, Zhu H. Regulation of Nrf2 Signaling. React Oxyg Species. 2019;8(24):312-322.

6. De Vita S, González-Burgos E, Terracciano S, Chini MG, Gómez-Serranillos MP, Bifulco G. Discovery of New Antioxidant Molecules Enhancing the Nrf2-Mediated Pathway: Docking Studies and Biological Evaluation. Int J Mol Sci. 2026;27(4):1862. doi:10.3390/ijms27041862

7. De Vita S, González-Burgos E, Terracciano S, Chini MG, Gómez-Serranillos MP, Bifulco G. Discovery of New Antioxidant Molecules Enhancing the Nrf2-Mediated Pathway: Docking Studies and Biological Evaluation. Int J Mol Sci. 2026;27(4):1862. doi:10.3390/ijms27041862

8. Medina-García M, Baeza-Morales A, Martínez-Peinado P, et al. Carotenoids and Their Interaction with the Immune System. Antioxidants. 2025;14(9):1111. doi:10.3390/antiox14091111

9. Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785-2791. doi:10.1002/jcc.21256

10. Krieger E, Dunbrack RL, Hooft RWW, Krieger B. Assignment of Protonation States in Proteins and Ligands: Combining pKa Prediction with Hydrogen Bonding Network Optimization. In: Baron R, ed. Computational Drug Discovery and Design. Vol 819. Methods in Molecular Biology. Springer New York; 2012:405-421. doi:10.1007/978-1-61779-465-0_25

11. Harris JA, Liu R, De Oliveira VM, Montelongo EV, Henderson JA, Shen J. GPU-Accelerated All-atom Particle-Mesh Ewald Continuous Constant pH Molecular Dynamics in Amber. Biophysics. Preprint posted online June 5, 2022. doi:10.1101/2022.06.04.494833

12. Huggins D. Comparing the performance of different AMBER protein forcefields, partial charge assignments, and water models for absolute binding free energy calculations. Preprint posted online January 31, 2022. doi:10.26434/chemrxiv-2022-l69v9

13. Peeples CA, Liu R, Shen J. Force Field Limitations of All-Atom Continuous Constant pH Molecular Dynamics. J Phys Chem B. 2024;128(47):11616-11624. doi:10.1021/acs.jpcb.4c05971

14. Batcho PF, Case DA, Schlick T. Optimized particle-mesh Ewald/multiple-time step integration for molecular dynamics simulations. J Chem Phys. 2001;115(9):4003-4018. doi:10.1063/1.1389854

15. Krieger E, Darden T, Nabuurs SB, Finkelstein A, Vriend G. Making optimal use of empirical energy functions: Force‐field parameterization in crystal space. Proteins Struct Funct Bioinforma. 2004;57(4):678-683. doi:10.1002/prot.20251

16. Krieger E, Vriend G. New ways to boost molecular dynamics simulations. J Comput Chem. 2015;36(13):996-1007. doi:10.1002/jcc.23899

17. Jalali-Jivan M, Rostamabadi H, Assadpour E, et al. Recent progresses in the delivery of β-carotene: From nano/microencapsulation to bioaccessibility. Adv Colloid Interface Sci. 2022;307:102750. doi:10.1016/j.cis.2022.102750

18. Molteni C, La Motta C, Valoppi F. Improving the Bioaccessibility and Bioavailability of Carotenoids by Means of Nanostructured Delivery Systems: A Comprehensive Review. Antioxidants. 2022;11(10):1931. doi:10.3390/antiox11101931

19. Patel J, Roy H, Khobragade DS, et al. Natural lipid-based nanoformulations for enhancing hepatoprotective activity: mechanisms, efficacy, and clinical translation. Health Nanotechnol. 2025;1(1):11. doi:10.1186/s44301-025-00010-8

20. Otani S, Miki S, Nakamura Y, Ishimoto K, Ago Y, Nakagawa S. Improved Bioavailability of β-Carotene by Amorphous Solid Dispersion Technology in Rats. J Nutr Sci Vitaminol (Tokyo). 2020;66(2):207-210. doi:10.3177/jnsv.66.207

21. Culletta G, Buttari B, Arese M, et al. Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects. Eur J Med Chem. 2024;270:116355. doi:10.1016/j.ejmech.2024.116355

22. Crisman E, Duarte P, Dauden E, et al. KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential. Med Res Rev. 2023;43(1):237-287. doi:10.1002/med.21925

23. Jiang ZY, Lu MC, Xu L, et al. Discovery of Potent Keap1–Nrf2 Protein–Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis. J Med Chem. 2014;57(6):2736-2745. doi:10.1021/jm5000529

24. Borges CV, Orsi RO, Maraschin M, Lima GPP. Oxidative stress in plants and the biochemical response mechanisms. In: Plant Stress Mitigators. Elsevier; 2023:455-468. doi:10.1016/B978-0-323-89871-3.00022-7

25. Ding Y, Fang Y, Moreno J, Ramanujam J, Jarrell M, Brylinski M. Assessing the similarity of ligand binding conformations with the Contact Mode Score. Comput Biol Chem. 2016;64:403-413. doi:10.1016/j.compbiolchem.2016.08.007

26. Medoro A, Jafar TH, Sallustio F, Scapagnini G, Saso L, Davinelli S. Computational Assessment of Carotenoids as Keap1-Nrf2 Protein–Protein Interaction Inhibitors: Implications for Antioxidant Strategies. Biochem Mosc. 2024;89(10):1681-1691. doi:10.1134/S0006297924100031

27. Alzain AA, Mukhtar RM, Abdelmoniem N, et al. Modulation of NRF2/KEAP1-Mediated Oxidative Stress for Cancer Treatment by Natural Products Using Pharmacophore-Based Screening, Molecular Docking, and Molecular Dynamics Studies. Molecules. 2023;28(16):6003. doi:10.3390/molecules28166003

28. Singh E, Matada GSP, Dhiwar PS, Patil RB, Pal R. In-silico based discovery of potential Keap1 inhibitors using the strategies of pharmacophore screening, molecular docking, and MD simulation studies. BioImpacts. Published online September 14, 2024:1. doi:10.34172/bi.30335

29. Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717. doi:10.1038/srep42717

Downloads

Published

2026-10-31

Issue

Section

Articles

How to Cite

An in silico Study of Carotenoids as Antioxidants through the KEAP1-NRF2 Pathway. (2026). International Journal of Cell and Biomedical Science, 5(14), 591-607. https://doi.org/10.59278/cbs.v5i14.116